Table 1.
Intervention (N = 8900) |
Control (N = 7901) |
|
---|---|---|
Hospital, number patients (%) | ||
Bispebjerg Hospital | 3451 (38.8%) | 3569 (45.2%) |
Herlev Hospital | 5449 (61.2%) | 4332 (54.8%) |
Patients | ||
Female sex, no. (%) | 4689 (52.7%) | 4175 (52.8%) |
Age (years), mean (SD) | 60.4 (20.8) | 60.9 (20.7) |
Charlson score, mean (SD) | 0.7 (1.5) | 0.7 (1.5) |
Length of hospital stay (days), mean (SD) | 4.4 (8.3) | 4.5 (8.7) |
In-hospital admission, no. (%) | 4461 (50.1) | 4031 (51.0) |
Biomarkers, median (IQR) | ||
Albumin (g/L) | 39 (35 to 43) | 39 (34 to 42) |
Creatinine (μmol/L) | 76 (62 to 94) | 75.0 (62 to 93) |
CRP (mg/L) | 5.0 (3.0 to 39.0) | 5.0 (3.0 to 41.0) |
Haemoglobin (mmol/L) | 8.3 (7.5 to 9.0) | 8.3 (7.6 to 9.1) |
suPAR (ng/ml) | 4.1 (2.9 to 6.0) | n.a. |
Subgroups, diagnoses at discharge | ||
Cancer, no. (%) | 559 (6.3%) | 471 (6%) |
Cardiovascular disease, no. (%) | 1918 (21.6%) | 1726 (21.8%) |
Infections, no. (%) | 1676 (18.8%) | 1584 (20%) |
Neurological disease, no. (%) | 936 (10.5%) | 864 (10.9%) |
Surgery during admission, no. (%) | 876 (9.8%) | 787 (10%) |
CRP C-reactive protein, IQR interquartile range, SD standard deviation, suPAR soluble urokinase plasminogen activator receptor